MetaSystems, a worldwide leader in microscopic imaging innovation, presented proof of concept results for Deep Learning - based pathogen classification on Gram stain slides.
- Automated Gram Sample Imaging
- Mycobacteria Detection
- Direct Multiplex Imaging
The rapid identification of pathogens in clinical environments is crucial for the successful and economic treatment of infectious diseases. MetaSystems offers fast identification tests and imaging solutions to improve infectious disease management and to reduce hospitalization costs.
The Boost for Gram Stain Analysis
Gram stains will have essential functions in the clinical microbiology laboratory for many years to come, despite the ongoing establishment of molecular testing and related approaches. Why? No other method provides information so quickly about specimen quality and organisms present for an early diagnosis. The assessment of specimen quality via Gram stain is the essential first step to determine if further steps are necessary, such as whether it is necessary to grow bacterial culture for subsequent testing.
The Metafer automated Gram reading and imaging platform holds many benefits for laboratories as well as clinicians, for example: automatic Gram reading can free staff from tedious, manual slide evaluation while image archiving allows decentralized assessment of results, regardless of the location of the main laboratory.
Learn more about the Gram Scanner system and your benefits.
The Easiest Mycobacteria Detection Ever
Pre-selecting patients for tuberculosis by manual microscopy of Auramine or Ziehl-Neelsen stained sputum smears is standard in most laboratories. However, manual microscopy of stained slides is a very time-consuming process. Automated slide scanning and image acquisition, combined with detection of mycobacteria by the Metafer slide scanning and automation platform saves many working hours and facilitates mycobacteria detection dramatically.
Specific Identification of Pathogens in Time of a Gram Stain
Direct Multiplex Imaging (DMI) is a novel hybridization technology for direct identification and differentiation of pathogenic microorganisms, even from challenging patient samples like sputum. Time-to-result (TTR), including sample preparation, takes just 35 minutes, thus making evidence-based antibiotic therapy possible at a very early stage. The assay for identification of bacteremia-causing pathogens is already available and an assay for identification of Pneumonia-causing pathogens is currently under pre-launch evaluation.